Kazuma Kishi

8.2k total citations
187 papers, 2.4k citations indexed

About

Kazuma Kishi is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Kazuma Kishi has authored 187 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Pulmonary and Respiratory Medicine, 47 papers in Epidemiology and 38 papers in Oncology. Recurrent topics in Kazuma Kishi's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (57 papers), Lung Cancer Treatments and Mutations (40 papers) and Lung Cancer Diagnosis and Treatment (33 papers). Kazuma Kishi is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (57 papers), Lung Cancer Treatments and Mutations (40 papers) and Lung Cancer Diagnosis and Treatment (33 papers). Kazuma Kishi collaborates with scholars based in Japan, Australia and United States. Kazuma Kishi's co-authors include Sakae Homma, Takeshi Fujii, Atsuko Kurosaki, Hironori Uruga, Kunihiko Yoshimura, Tadasu Kohno, Atsushi Miyamoto, Noriko Motoi, Hisashi Takaya and Sakashi Fujimori and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kazuma Kishi

174 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuma Kishi Japan 25 1.7k 396 392 302 295 187 2.4k
Naohiro Kajiwara Japan 27 1.6k 1.0× 461 1.2× 358 0.9× 222 0.7× 452 1.5× 91 2.5k
Lary A. Robinson United States 28 1.8k 1.1× 791 2.0× 212 0.5× 109 0.4× 283 1.0× 99 3.0k
Seth Force United States 30 1.3k 0.8× 330 0.8× 258 0.7× 151 0.5× 188 0.6× 109 2.3k
Jeremy J. Erasmus United States 31 2.2k 1.3× 613 1.5× 497 1.3× 105 0.3× 1.1k 3.6× 90 3.6k
Eun Jin Chae South Korea 29 1.4k 0.8× 122 0.3× 366 0.9× 386 1.3× 919 3.1× 119 2.7k
Marcelo Sánchez Spain 24 925 0.6× 340 0.9× 509 1.3× 177 0.6× 297 1.0× 106 1.9k
Nishita Kothary United States 30 825 0.5× 257 0.6× 406 1.0× 167 0.6× 634 2.1× 112 2.4k
Michael A. Jantz United States 25 2.5k 1.5× 360 0.9× 234 0.6× 131 0.4× 444 1.5× 71 3.1k
Gregory L. Aughenbaugh United States 22 1.9k 1.1× 308 0.8× 301 0.8× 183 0.6× 978 3.3× 37 2.7k
James D. Murphy United States 18 599 0.4× 193 0.5× 201 0.5× 226 0.7× 268 0.9× 67 1.4k

Countries citing papers authored by Kazuma Kishi

Since Specialization
Citations

This map shows the geographic impact of Kazuma Kishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuma Kishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuma Kishi more than expected).

Fields of papers citing papers by Kazuma Kishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuma Kishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuma Kishi. The network helps show where Kazuma Kishi may publish in the future.

Co-authorship network of co-authors of Kazuma Kishi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuma Kishi. A scholar is included among the top collaborators of Kazuma Kishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuma Kishi. Kazuma Kishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamoto, Susumu, Hideya Kitamura, Tae Iwasawa, et al.. (2025). Differences in Radiological and Pathological Findings by ANCA‐Subtype in ANCA‐Positive Idiopathic Interstitial Pneumonias. The Clinical Respiratory Journal. 19(3). e70061–e70061.
2.
Kobayashi, Takayuki, Kageaki Watanabe, Yukio Hosomi, et al.. (2024). Clinical outcomes of patients with EGFR-mutated NSCLC developing interstitial lung disease during first-line osimertinib therapy: a sub-analysis of the Reiwa study. Japanese Journal of Clinical Oncology. 55(3). 275–282.
3.
Hirata, Tsuyoshi, Kageaki Watanabe, Yukio Hosomi, et al.. (2024). Observational study of the efficacy and safety of first-line osimertinib and later treatments for uncommon epidermal growth factor receptor-activating mutation-positive advanced non-small cell lung cancer. Japanese Journal of Clinical Oncology. 55(3). 269–274. 1 indexed citations
4.
Bando, Masashi, Sakae Homma, Hiroshi Date, et al.. (2024). Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition. Respiratory Investigation. 62(3). 402–418. 5 indexed citations
5.
Iwanami, Yuji, Keiko Nakao, Yasuhiko Nakamura, et al.. (2024). Impact of Controlling Nutritional Status Score on Mortality in Elderly Patients with Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 13(10). 2825–2825. 3 indexed citations
6.
Sakamoto, Susumu, Sakae Homma, Hiroshige Shimizu, et al.. (2023). Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease. Scientific Reports. 13(1). 17616–17616. 11 indexed citations
7.
Kato, Chiaki, Takahiro Yoshizawa, Kazutoshi Isobe, et al.. (2023). Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1‐rearranged non‐small cell lung cancer. SHILAP Revista de lepidopterología. 11(10). e01217–e01217. 1 indexed citations
8.
Iwanami, Yuji, Keiko Nakao, Yasuhiko Nakamura, et al.. (2022). Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis. Biomedicines. 10(10). 2556–2556. 2 indexed citations
9.
Yoshizawa, Takahiro, Ken Uchibori, Mitsugu Araki, et al.. (2021). Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity. npj Precision Oncology. 5(1). 32–32. 16 indexed citations
10.
Uchino, Hiroshi, Masahiko Miyagi, Kazutoshi Isobe, et al.. (2021). Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan. Diabetes Metabolic Syndrome and Obesity. Volume 14. 773–781. 6 indexed citations
11.
Sakai, Takashi, Atsushi Sano, Yoko Azuma, et al.. (2021). Preoperative undernutrition predicts postoperative complications of acute empyema. Health Science Reports. 4(1). e232–e232. 2 indexed citations
12.
Kadota, Tsukasa, Yusuke Yoshioka, Yu Fujita, et al.. (2020). Extracellular Vesicles from Fibroblasts Induce Epithelial-Cell Senescence in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 63(5). 623–636. 94 indexed citations
13.
Miyamoto, Atsushi, Atsuko Kurosaki, Yui Takahashi, et al.. (2018). Reduced area of the normal lung on high-resolution computed tomography predicts poor survival in patients with lung cancer and combined pulmonary fibrosis and emphysema. Respiratory Investigation. 57(2). 140–149. 5 indexed citations
14.
Takahashi, Yui, Hironori Uruga, Takeshi Fujii, et al.. (2016). Antemortem diagnosis of pulmonary tumor thrombotic microangiopathy in a patient with recurrent breast cancer: a case report. BMC Cancer. 16(1). 666–666. 11 indexed citations
15.
Kadoya, Noriyuki, Kengo Ito, Kazuma Kishi, et al.. (2016). Evaluation of four-dimensional computed tomography (4D-CT)-based pulmonary ventilation: The high correlation between 4D-CT ventilation and 81mKr-planar images was found. Radiotherapy and Oncology. 119(3). 444–448. 10 indexed citations
16.
Yoshii, Yutaka, Kenichiro Shimizu, Miyuki Morozumi, et al.. (2014). Multiplex real-time polymerase chain reaction is useful in diagnosing pathogens causing community-acquired pneumonia including atypical bacteria and viruses. European Respiratory Journal. 44(Suppl 58). P4935–P4935. 1 indexed citations
17.
Satō, Toshihiko, Satoshi Teramukai, Haruhiko Kondo, et al.. (2013). Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. Journal of Thoracic and Cardiovascular Surgery. 147(5). 1604–1611.e3. 217 indexed citations
18.
Uruga, Hironori, Takeshi Fujii, Atsuko Kurosaki, et al.. (2013). Pulmonary tumor thrombotic microangiopathy: A clinical analysis of 30 autopsy cases. European Respiratory Journal. 42(Suppl 57). 1800–1800. 39 indexed citations
19.
Kohno, Tadasu, Sakashi Fujimori, Kazuma Kishi, & Takeshi Fujii. (2010). Safe and Effective Minimally Invasive Approaches for Small Ground Glass Opacity. The Annals of Thoracic Surgery. 89(6). S2114–S2117. 27 indexed citations
20.
Kishi, Kazuma, Sakae Homma, Atsuko Kurosaki, et al.. (2003). [Pulmonary cryptococcosis combined with pulmonary tuberculosis].. PubMed. 41(1). 30–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026